You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triplet

Showing 1 - 25 of 375
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Metastatic Colorectal Cancer Trial in Cairo (FOLFOXIRI Protocol)

Completed
  • Metastatic Colorectal Cancer
  • FOLFOXIRI Protocol
  • Cairo, El Manial, Egypt
    Kasr El AiniH
Mar 30, 2022

Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)

Not yet recruiting
  • Recurrent/Advanced Gastric Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 22, 2022

Intrahepatic Cholangiocarcinoma Trial in Fairfax (Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment,

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Induction Chemotherapy Triplet Therapy
  • +2 more
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jun 14, 2022

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Locally Advanced Rectal Cancer Trial in Beijing (FOLFOXIRI)

Completed
  • Locally Advanced Rectal Cancer
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese ACademy of Medic
Jan 29, 2021

Locally Advanced Rectal Cancer Trial in Pisa (drug, radiation, procedure)

Recruiting
  • Locally Advanced Rectal Cancer
  • Pisa, Italy
    U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Univ
Mar 9, 2022

Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New

Recruiting
  • Locally Advanced Rectal Carcinoma
  • +2 more
  • Gainesville, Florida
  • +1 more
Jan 4, 2023

NIPD on cffDNA for Triplet Repeat Diseases

Active, not recruiting
  • Myotonic Dystrophy 1
  • +2 more
  • Non invasive prenatal diagnosis
  • Montpellier, France
    CHU Montpellier
Jan 4, 2021

Resectable Gastric and Gastroesophageal Junction Adenocarcinoma Trial in Norway, Sweden (Fluorouracil, Oxaliplatin, Irinotecan)

Recruiting
  • Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
  • Oslo, Norway
  • +3 more
Mar 11, 2021

Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou, Guanzhou, Changsha (Hepatic

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Hepatocellular Carcinoma by BCLC Stage
  • Hepatic Arterial Infusion(mFOLFOX7) combined with Bevacizumab and Sintilimab
  • Guangzhou, Guangdong, China
  • +4 more
May 4, 2022

Metastatic Gastric Cancer Trial in Guangzhou (Irinotecan, Oxaliplatin, 5-fluorouracil)

Recruiting
  • Metastatic Gastric Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Jul 13, 2021

Stroke Trial in Tübingen (Negative peak triggered 100 Hz triplet burst TMS, 1 Hz rTMS)

Recruiting
  • Stroke
  • Negative peak triggered 100 Hz triplet burst TMS
  • 1 Hz rTMS
  • Tübingen, Baden-Württemberg, Germany
    University Hospital Tübingen, Department for Neurology and Strok
Aug 10, 2021

Non Invasive Prenatal Diagnosis Trial in France (Non invasive prenatal diagnosis)

Completed
  • Non Invasive Prenatal Diagnosis
  • Non invasive prenatal diagnosis
  • Bordeaux, France
  • +7 more
Dec 29, 2020

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Metastatic Colorectal Cancer Trial in Italy (Panitumumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
  • +3 more
Oct 5, 2021

Ovarian Cancer Trial in Denmark, Finland, Norway (Niraparib, Bevacizumab, TSR042)

Withdrawn
  • Ovarian Cancer
  • Copenhagen, Sjaelland, Denmark
  • +7 more
Jul 9, 2021

Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Amiens, France
  • +20 more
Jul 26, 2022

Malignant Pleural Mesothelioma, Solid Tumors Trial in United States (pemetrexed, cisplatin and CBP501, pemetrexed and cisplatin,

Completed
Has Results
  • Malignant Pleural Mesothelioma
  • Solid Tumors
  • pemetrexed, cisplatin and CBP501
  • +2 more
  • Scottsdale, Arizona
  • +11 more
Jun 30, 2021

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Pomalidomide)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
Dec 6, 2022

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023